- Home
- CSL vs ICLR Comparison
CSL vs ICLR Comparison
Compare CSL & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSL
- ICLR
- Stock Information
- Founded
- CSL 1917
- ICLR 1990
- Country
- CSL United States
- ICLR Ireland
- Employees
- CSL N/A
- ICLR N/A
- Industry
- CSL Specialty Chemicals
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- CSL Industrials
- ICLR Health Care
- Exchange
- CSL Nasdaq
- ICLR Nasdaq
- Market Cap
- CSL 16.2B
- ICLR 14.3B
- IPO Year
- CSL N/A
- ICLR 1998
- Fundamental
- Price
- CSL $329.23
- ICLR $163.70
- Analyst Decision
- CSL Buy
- ICLR Buy
- Analyst Count
- CSL 6
- ICLR 15
- Target Price
- CSL $386.67
- ICLR $211.36
- AVG Volume (30 Days)
- CSL 550.9K
- ICLR 988.1K
- Earning Date
- CSL 10-29-2025
- ICLR 10-22-2025
- Dividend Yield
- CSL 1.34%
- ICLR N/A
- EPS Growth
- CSL N/A
- ICLR N/A
- EPS
- CSL 17.56
- ICLR 7.47
- Revenue
- CSL $5,015,100,000.00
- ICLR $8,102,602,000.00
- Revenue This Year
- CSL $1.17
- ICLR N/A
- Revenue Next Year
- CSL $2.98
- ICLR $0.89
- P/E Ratio
- CSL $18.74
- ICLR $21.80
- Revenue Growth
- CSL 0.14
- ICLR N/A
- 52 Week Low
- CSL $311.41
- ICLR $125.10
- 52 Week High
- CSL $472.66
- ICLR $231.89
- Technical
- Relative Strength Index (RSI)
- CSL 45.60
- ICLR 37.78
- Support Level
- CSL $320.78
- ICLR $162.36
- Resistance Level
- CSL $332.30
- ICLR $172.99
- Average True Range (ATR)
- CSL 9.22
- ICLR 8.45
- MACD
- CSL 0.55
- ICLR -2.71
- Stochastic Oscillator
- CSL 30.38
- ICLR 11.53
About CSL Carlisle Companies Incorporated
Carlisle Companies Inc is a holding company. The company manufactures and sells single-ply roofing products and warranted systems and accessories for the commercial building industry. The company is organized into two segments including Carlisle Construction Materials and Carlisle Weatherproofing Technologies. The company's product portfolio includes moisture protection products, protective roofing underlayments, integrated air and vapor barriers, spray polyurethane foam and coating systems, and others. The majority of the company's revenue comes from the Carlisle Construction Materials segment, and more than half of the total revenue is earned in the United States.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.